Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON
EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Our common stock commenced
trading on the NASDAQ Capital Market, or NASDAQ, under the symbol “IPW” on May 14, 2021. Prior to that time, our common stock
was not traded on any exchange or quoted on any over the counter market. The prices set forth below reflect the quarterly high and low
sales prices per share for our common stock for the fiscal year ended June 30, 2022, as reported by the NASDAQ:
High
Low
2022
First Quarter
$ 8.78
$ 3.92
Second Quarter
3.97
2.08
Third Quarter
2.43
1.27
Fourth Quarter
1.85
1.00
2021
Fourth Quarter
$ 8.35
$ 4.83
Holders
As of September 27, 2022,
we had 23 holders of record of our common stock and 29,572,382 shares of common stock issued and outstanding.
Dividends
We have never paid cash dividends
on our common stock. Holders of our common stock are entitled to receive dividends, if any, declared and paid from time to time by the
board of directors out of funds legally available. We intend to retain any earnings for the operation and expansion of our business and
do not anticipate paying cash dividends on our common stock in the foreseeable future. Any future determination as to the payment of cash
dividends will depend upon future earnings, results of operations, capital requirements, our financial condition and other factors that
our board of directors may consider.
Equity Compensation
Plans
2020 Equity Incentive Plan
The total number of underlying
shares of the Company’s common stock available for grant to directors, officers, key employees and consultants of the Company or
a subsidiary of the Company under the Company’s Amended and Restated 2020 Equity Inventive Plan (the “Equity Incentive Plan”)
was 5,000,000 shares. Grants made under the Equity Incentive Plan must be approved by the Company’s Board of Directors.
31
The following table provides
information as of June 30, 2022 about our equity compensation plans and arrangements.
Plan category
Number of
securities to be
issued upon
exercise of
outstanding
options,
warrants and
rights
Weighted-
average
exercise price of
outstanding
options,
warrants and
rights
Number of
securities
remaining
available for
future issuance
under equity
compensation
plans
Equity compensation plans approved by security holders
3,469,674
$ 1.12
1,530,326
Equity compensation plans not approved by security holders (1)
–
–
–
Total
3,469,974
$ 1.12
1,530,326
Recent Sales of Unregistered Securities
Set forth below is information
regarding all securities issued by us within the past three years. Also included is the consideration received by us for such securities,
if any, and information relating to the section of the Securities Act, or rule of the SEC, under which exemption from registration was
claimed.
On February 15, 2022, pursuant
to the terms of a share transfer framework agreement (the “Transfer Agreement”) for acquisition of 100% of the ordinary shares
of Anivia Limited (“Anivia”) and its subsidiaries and VIE, the Company issued 3,083,700 restricted shares (subject to a lock-up
period of 180 days and insider trading rules) of the Company’s common stock to White Cherry Limited, a BVI company (“White
Cherry”). Please see Note 4 of the Notes to Consolidated Financial Statements for details.
On January 27, 2021, the Company
completed a private placement offering pursuant to which the Company sold to two accredited investors an aggregate of $3,000,000 in convertible
notes with a 6% interest per annum (the “Convertible Note”) and warrants to purchase shares of Class A Common Stock equaling
80% of the number of shares of Class A Common Stock issuable upon conversion of the Convertible Notes. The warrants shall be exercisable
for a period of three years from the IPO completion date at a per share exercise price equal to the IPO. The Convertible Notes shall be
automatically converted into the Company’s Class A Common Stock upon a qualified IPO (the “Mandatory Conversion”) or
repayable in cash at the option of the holders of the Convertible Notes with repayment to commence six months after January 27, 2021.
The Convertible Notes convert at a price equal to the lesser of (a) a price representing a 30% discount to the public offering price per
share of the Class A Common Stock in this Offering, or (b) a price representing a 30% discount to the price per share equal to dividing
$200 million by the total number of (x) outstanding shares of Class A Common Stock immediately prior to the IPO, (y) the number of Class
A Common Stock issuable upon conversion of the 34,500 shares of Series A Preferred Stock, and (z) the number of Class A Common Stock issuable
upon conversion of all outstanding Convertible Notes. Any interest accrued on the Convertible Note will be waived upon conversion.
In connection with the convertible
note offering, the Company issued placement agent warrants to purchase 7.0% of the shares of Class A Common Stock underlying the Convertible
Notes exercisable at the conversion price of the Convertible Note (the “Conversion Price”). The placement agent warrants were
exercisable for a period of five years from the issuance date and are treated as a debt issuance cost.
32
On December 30, 2020, we issued
a total of 34,500 shares of Series A convertible preferred stock, par value $0.001 per share, to a total of three accredited investors,
at a purchase price of $10.00 per share, for a total purchase price of $345,000. Boustead Securities, LLC acted as placement agent in
the Series A preferred offering, and received compensation of $27,600 and warrants to purchase 2,415 shares of Series A convertible preferred
stock. The shares were issued to accredited investors pursuant to exemption from registration under Rule 506(b) of Regulation D under
the Securities Act. Following completion of our IPO, on May 14, 2021, the placement agent warrants issued in relation to the 2020 and
2021 private placements were exercised in full.
On October 20, 2020, we issued
14,000,000 shares of our Class B Common Stock, par value $0.001 per share, to our two founders, Allan Huang and Chenlong Tan in exchange
for a total purchase price of $14,000. The shares were issued to our two founders pursuant to an exemption from registration under Section
4(a)(2) of the Securities Act. The shares of Class B Common Stock entitled the holders to 10 votes per share and were eligible to convert
into shares of Class A Common Stock, on a one-for-ten basis, at any time following twelve (12) months after the Company’s completion
of its initial public offering. On April 14, 2021, the Company amended its articles of incorporation to permit immediate conversion of
the Class B Common Stock and the Company’s two founders converted all of their 14,000,000 shares of Class B Common Stock into 1,400,000
additional shares of Class A Common Stock, bringing their total ownership to an aggregate of 16,046,668 shares of Class A Common Stock
or 60.67% of the 26,448,663 shares of Class A Common Stock t. Effective April 14, 2021, the Company amended and restated its Articles
of Incorporation to permit the immediate conversion of the Class B Common Stock and to eliminate any future issuances of Class B Common
Stock. On April 23, 2021, the Company further amended and restated its articles of incorporation to eliminate the Class A and Class B
Common Stock and authorize for issuance 180,000,000 shares which are solely designated as Common Stock.
On January 15, 2020, we issued
a total of 204,496 shares of our Common Stock to Sugarmade Inc. as a refund of cash related to a terminated merger agreement. The shares
were issued to Sugarmade Inc. pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act.
In April 2018 and July 2020,
we issued a total of 20,000,000 shares of our Common Stock, par value $0.001 per share, to our two founders and four key employees. The
shares were issued to our founders and key employees pursuant to an exemption from registration under Section 4(a)(2) of the Securities
Act.
Issuer Purchases of
Equity Securities
None.
Use of Proceeds
None.
ITEM 6. SELECTED FINANCIAL DATA
Not required for smaller reporting
companies.
33
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.